Cardinal Health, Inc. $CAH Shares Sold by Prudential PLC

Prudential PLC cut its position in Cardinal Health, Inc. (NYSE:CAH) by 23.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,733 shares of the company’s stock after selling 2,961 shares during the quarter. Prudential PLC’s holdings in Cardinal Health were worth $2,000,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in CAH. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $25,000. Elyxium Wealth LLC purchased a new stake in shares of Cardinal Health in the fourth quarter valued at about $34,000. Barnes Dennig Private Wealth Management LLC boosted its stake in shares of Cardinal Health by 38.7% during the fourth quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock worth $39,000 after buying an additional 53 shares during the period. JPL Wealth Management LLC purchased a new position in shares of Cardinal Health during the third quarter worth about $31,000. Finally, Turning Point Benefit Group Inc. purchased a new stake in Cardinal Health during the 3rd quarter valued at approximately $31,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.0%

CAH stock opened at $205.79 on Monday. The firm has a 50 day moving average of $202.53 and a 200-day moving average of $208.59. The company has a market cap of $48.20 billion, a price-to-earnings ratio of 31.47, a PEG ratio of 1.12 and a beta of 0.52. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the prior year, the firm posted $2.35 EPS. The company’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 1.0%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.19%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on CAH shares. Morgan Stanley boosted their target price on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 target price on shares of Cardinal Health in a report on Monday, March 9th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Sunday. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Finally, Argus increased their target price on Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.